OHAM Mission Statement
The mission of the Office of HIV and AIDS Malignancy (OHAM) is to facilitate and provide broad oversight for HIV/AIDS and HIV malignancy research throughout the National Cancer Institute (NCI). OHAM works with the NCI Director, the NCI Divisions, and other Offices in the NCI in managing the HIV/AIDS and HIV malignancy research portfolio. OHAM coordinates and prioritizes NCI research in HIV/AIDS and HIV malignancy and, in addition, directly initiates and manages certain research programs. AIDS research is conducted throughout the National Institutes of Health (NIH), and OHAM interfaces with the Office of AIDS Research and other Institutes and Centers in the NIH to effectively coordinate this research effort.
The ultimate goal of the OHAM/NCI research effort is to effectively prevent, diagnose, and treat HIV/AIDS, HIV-associated malignancies, and other malignancies developing in individuals with HIV infection. HIV infection and HIV-associated malignancies have a profound impact throughout the world, and OHAM research accordingly has both a domestic and an international focus.
OHAM strives to optimize the use of research resources throughout the NCI to advance knowledge in HIV/AIDS and HIV malignancy. The aim of this effort is to effectively prevent, diagnose, and treat these conditions, both in the United States and throughout the rest of the world.